Elazar S Rabbani

New York, NY, United States of America

Elazar S Rabbani

USPTO Granted Patents = 122 

 

 

Average Co-Inventor Count = 3.0

ph-index = 18

Forward Citations = 1,977(Granted Patents)

Forward Citations (Not Self Cited) = 1,680(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • NY, NY (US) (2015)
  • New York, NY (US) (1979 - 2024)

Company Filing History:


Years Active: 1979-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Fluorescence Quencher
Sphingosine Pathway Modulation
Immunomodulatory Compositions
Nucleic Acid Detection
Multisignal Labeling Reagents
Assay Development
Chimeric Compositions
Real-Time Nucleic Acid Detection
Quantitative Detection Processes
Pharmaceutical Compositions
Analytical Techniques
Organelle Tracing
122 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Elazar S Rabbani - Pioneering Cancer Treatment Solutions

Introduction:

Elazar S Rabbani, a prolific inventor based in New York, NY, is renowned for his groundbreaking work in the field of oncology. With an impressive portfolio comprising 120 patents, Rabbani has significantly contributed to the advancement of cancer research and treatment methodologies.

Latest Patents:

Among his latest patents is the development of assays for detecting modified compounds. These methods and compositions allow for the precise separation, isolation, and quantification of chemically, enzymatically, or catalytically modified compounds, offering invaluable insights for researchers and healthcare practitioners. Additionally, Rabbani has innovated sphingosine pathway modulating compounds for the treatment of cancers, presenting novel therapeutic approaches for combating various forms of cancer and myeloproliferative disorders.

Career Highlights:

Rabbani's innovative spirit has led him to collaborate with prominent companies such as Enzo Life Sciences, Inc. and Enzo Biochem, Inc., where his expertise has been instrumental in driving forward cutting-edge research and product development initiatives. His dedication to revolutionizing cancer treatment has earned him a reputation as a leader in the biopharmaceutical industry.

Collaborations:

Throughout his career, Rabbani has had the privilege of working alongside accomplished professionals such as Jannis G Stavrianopoulos and James J Donegan. These collaborations have not only enriched his own research endeavors but have also fostered a culture of innovation and knowledge-sharing within the scientific community.

Conclusion:

Elazar S Rabbani's remarkable contributions to cancer research and treatment underscore his unwavering commitment to pushing the boundaries of scientific exploration. With a diverse portfolio of patents and a history of successful collaborations, Rabbani continues to inspire future generations of inventors and researchers in the pursuit of transformative healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…